Multistate modeling for survival analysis in critically ill patients treated with meropenem
Abstract Appropriate antibiotic dosing to ensure early and sufficient target attainment is crucial for improving clinical outcome in critically ill patients. Parametric survival analysis is a preferred modeling method to quantify time‐varying antibiotic exposure - response effects, whereas bias may...
Saved in:
Main Authors: | Yaru Peng (Author), Iris K. Minichmayr (Author), Han Liu (Author), Feifan Xie (Author), Lena E. Friberg (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against <em>Pseudomonas aeruginosa</em> to Clinical Settings
by: Iris K. Minichmayr, et al.
Published: (2022) -
Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel
by: Sreenath M. Krishnan, et al.
Published: (2021) -
External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients
by: Nan Yang, et al.
Published: (2022) -
Defining Exposure Predictors of Meropenem That Are Associated with Improved Survival for Severe Bacterial Infection: A Preclinical PK/PD Study in Sepsis Rat Model
by: Yan Wang, et al.
Published: (2022) -
Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?
by: Letao Li, et al.
Published: (2023)